Clinical Trial Update: Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating Loxenatide plus LNG-IUS for endometrial hyperplasia with atypical cells in patients with obesity and fertility concerns has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia with Atypical Cells
• Infertility
• Obesity

Drugs mentioned

• Levonorgestrel intrauterine system (LNG-IUS) (Levonorgestrel intrauterine system)
• Loxenatide (loxenatide)

Snippet

Sponsor: Fudan University | Conditions: Atypical Endometrial Hyperplasia, Obesity | Phase 2, Phase 3 | Status: COMPLETED